A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
Yinghui Jin(Wuhan University), Xinghuan Wang(Wuhan University), Jian‐Chuan Xia(Sun Yat-sen University), Yingwen Zhang(Shanghai Jiao Tong University), Yong Han(Soochow University), Xuequn Ren(Henan University Huaihe Hospital and Huaihe Clinical Institute), Chaojie Wei(Zhongyuan University of Technology), Zhiyong Peng(Wuhan University), Yunbao Pan(Wuhan University), Xiaomei Yao(Shanxi Medical University), Dong-Fang Wu(Wuhan University), Yin-Gao Zhang(Wuhan University), Ming-Juan Zhao(Wuhan University), Taisheng Ye(Wuhan University), Xian‐Tao Zeng(Fujian Medical University), Ying Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Likai Lin(Xihua University), Lin Cai(Wuhan University), Huimin Sun(Wuhan University), Cheng Fang(Chongqing Public Health Medical Center), Yong Xiong(Wuhan University), Hong Cheng(Guangxi Medical University), Yipin Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), Hao Zi(Hubei University of Medicine), Yufeng Yuan(Wuhan University), Xiaochun Zhang(China Medical University), Bo Hu(Wuhan University), Luqi Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yirong Li(Wuhan University), Tong Deng(Wannan Medical College), Jing Ma(St. Jude Children's Research Hospital), Binghui Li(Wuhan University), Huamin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongyan Wang(Beijing Normal University), Yan Zhao(Hubei University of Chinese Medicine), Zhenshun Cheng(Wuhan University), Ke Liang(Wuhan University), Di Huang(Zhejiang University), Haibo Xu(Guangzhou Medical University), Qiao Huang(Wuhan University), Linlu Ma(Wuhan University), Fen Hu(Wuhan University), Hong Weng(Wuhan University), Zhenyu Pan(Wuhan University)
Cited by 2,363
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?
|Military Medical Research|2020|1.6k
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853